Bridgeway Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2
| Closed | -$48K | – | 1453 |
|
|
2022
Q2 | $48K | Buy |
+2
| New | +$48K | ﹤0.01% | 1283 |
|
|
2022
Q1 | – | Hold |
0
| – | -$5K | – | 1306 |
|
|
2021
Q4 | – | Hold |
0
| – | -$9K | – | 1258 |
|
|
2021
Q3 | – | Hold |
0
| – | -$238K | – | 1281 |
|
|
2021
Q2 | – | Hold |
0
| – | -$339K | – | 1242 |
|
|
2021
Q1 | – | Hold |
0
| – | -$179K | – | 1202 |
|
|
2020
Q4 | – | Hold |
0
| – | -$222K | – | 1222 |
|
|
2020
Q3 | – | Hold |
0
| – | -$161K | – | 1159 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1179 |
|
|
2016
Q4 | – | Hold |
0
| – | -$66K | – | 1465 |
|
|
2016
Q3 | – | Hold |
0
| – | -$188K | – | 1392 |
|
|
2016
Q2 | – | Hold |
0
| – | -$228K | – | 1316 |
|
|
2016
Q1 | – | Hold |
0
| – | -$724K | – | 1280 |
|
|
2015
Q4 | – | Hold |
0
| – | -$499K | – | 904 |
|
|
2015
Q3 | – | Hold |
0
| – | -$578K | – | 1029 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1005 |
|